Emily Bodnar

Analyst-Equity chez H. C. Wainwright & Co. LLC

Profil

Ms. Emily Bodnar is a Vice President & Senior Healthcare Analyst at H.
C.
Wainwright & Co. LLC.
Ms. Bodnar joined the firm in January 2022.
Her research focuses on the Biotechnology and Women’s Healthcare industries.
Prior to joining H.C.
Wainwright, Ms. Bodnar was a Senior Equity Research Associate at Cantor Fitzgerald assisting in coverage of small/mid and large-cap biotechnology companies.
She also worked as an Equity Research Associate at Berenberg Capital Markets assisting in coverage of small/mid-cap biotechnology companies.
Ms. Bodnar graduated summa cum laude from Binghamton University where she received a Bachelor of Science.
She has also taken several Biology and Immunology courses from Johns Hopkins University and Rice University.

Postes actifs de Emily Bodnar

Sociétés	Poste	Début
H. C. Wainwright & Co. LLC	Analyst-Equity	01/01/2022

Anciens postes connus de Emily Bodnar

Sociétés	Poste	Fin
Cantor Fitzgerald & Co.	Analyst-Equity	01/12/2021
Berenberg Capital Markets LLC	Analyst-Equity	01/09/2020